Insights Into Alignment Healthcare (ALHC) Q4: Wall Street Projections for Key Metrics

Core Insights - Alignment Healthcare (ALHC) is projected to report a quarterly loss of $0.18 per share, marking a 28$677.04 million, reflecting a year-over-year increase of 45.5% [1] - There has been no revision in the consensus EPS estimate for the quarter over the past 30 days, indicating stability in analysts' projections [1] Revenue Estimates - The average estimate for 'Revenues- Other' is $7.48 million, showing a year-over-year change of +17.2$668.26 million, indicating a change of +45.6% from the prior-year quarter [4] Key Metrics - The 'Medical Benefit Ratio' is projected to be 89.4%, consistent with the year-ago figure [4] - Analysts estimate that 'Health Plan Membership - Ending' will reach 185,005, compared to 119,200 in the previous year [4] Stock Performance - Shares of Alignment Healthcare have experienced a -12% return over the past month, in contrast to the Zacks S&P 500 composite's -1.8% change [5] - The company holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near future [5]